Article
G9a Promotes Breast Cancer Recurrence Through Repression of a Pro-inflammatory Program
medRxiv · 2020 · Mabe, N. W.; Wolery, S. E.; Newcomb, R.; Meingasner, R. C.; Vilona, B. A.; LIN, C.-C.; Lupo, R.; Chi, J.-T. A.; Alvarez, J. V.
Key facts
| Title | G9a Promotes Breast Cancer Recurrence Through Repression of a Pro-inflammatory Program |
|---|---|
| First author | Mabe, N. W.; Wolery, S. E.; Newcomb, R.; Meingasner, R. C.; Vilona, B. A.; LIN, C.-C.; Lupo, R.; Chi, J.-T. A.; Alvarez, J. V. |
| Journal | medRxiv |
| Published | Jan 9, 2020 |
| DOI | 10.1101/2020.01.09.900183 |
| Devices mentioned | BK110039, DEN000008, K022086, K103302 |
| Product codes mentioned | JCI, JJH, KIT, NDS, NJT, OOI, PFT, PCA |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1